Utah Medical Products, Inc. (FRA:UTM)
Germany flag Germany · Delayed Price · Currency is EUR
57.00
+1.00 (1.79%)
Last updated: Feb 23, 2026, 8:06 AM CET

Utah Medical Products Ratios and Metrics

Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
183153201277341321
Market Cap Growth
-4.51%-24.18%-27.18%-18.96%6.29%27.96%
Enterprise Value
11181116197277265
Last Close Price
56.0047.6056.2874.49--
PE Ratio
19.0815.8915.0318.3822.1424.69
PS Ratio
5.594.655.106.096.987.44
PB Ratio
1.811.501.782.383.193.41
P/TBV Ratio
2.061.722.072.794.034.85
P/FCF Ratio
--14.2814.1217.9317.68
P/OCF Ratio
--14.0613.7217.2517.22
EV/Sales Ratio
3.392.472.944.345.656.14
EV/EBITDA Ratio
9.066.646.498.8011.0211.51
EV/EBIT Ratio
11.458.357.6511.8114.9315.95
EV/FCF Ratio
--8.2410.0614.5314.58
Debt / Equity Ratio
0.000.000.000.000.000.00
Debt / EBITDA Ratio
0.020.020.020.010.010.02
Debt / FCF Ratio
--0.020.010.020.02
Net Debt / Equity Ratio
-0.72-0.72-0.70-0.72-0.65-0.56
Net Debt / EBITDA Ratio
-5.96-5.96-4.46-3.74-2.79-2.32
Net Debt / FCF Ratio
---5.66-4.28-3.67-2.93
Asset Turnover
0.310.310.320.390.440.43
Inventory Turnover
1.971.971.822.192.612.83
Quick Ratio
34.3634.3623.1820.4413.5217.65
Current Ratio
37.6237.6225.6422.5615.0919.54
Return on Equity (ROE)
9.54%9.54%11.29%13.72%14.88%14.09%
Return on Assets (ROA)
5.82%5.82%7.62%8.89%10.33%10.38%
Return on Invested Capital (ROIC)
26.84%26.62%36.84%40.56%36.65%29.85%
Return on Capital Employed (ROCE)
9.50%9.50%13.20%14.10%16.80%16.90%
Earnings Yield
5.24%6.30%6.65%5.44%4.52%4.05%
FCF Yield
--7.00%7.08%5.58%5.66%
Dividend Yield
1.90%2.19%2.07%1.44%--
Payout Ratio
--30.70%25.74%19.20%77.53%
Buyback Yield / Dilution
7.51%7.51%3.68%0.16%0.46%0.33%
Total Shareholder Return
9.42%9.71%5.75%1.60%0.46%0.33%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.